Filter posts

Q&A with ExonHit Therapeutics’ Loïc Maurel, MD

We recently spoke with Loïc Maurel, M.D., president of ExonHit Therapeutics’ Management Board, one of …

Weekly Blog Roundup

This week in the blogosphere there’s a lot of chatter about synthetic biology. The Columbia …

WORLD FOOD DAY 2009: Agricultural Biotechnology's Fight Against Hunger

Hundreds of major media outlets covered the October 15th speech given by Bill Gates’ at …

All Your Eggs in One Basket

Biofuels Digest reported this week that DoE Secretary Chu told attendees of an alternative energy …

Inovio begins HIV clinical trial of DNA vaccine

Inovio Biomedical Corporation (NYSE Amex: INO) and the HIV Vaccine Trials Network (HVTN) initiated a …

Methylgene to receive equity investment from Otsuka Pharmaceutical

MethylGene Inc. (TSX: MYG) agreed to issue 3,686,182 common shares to Otsuka Pharmaceutical Co., Ltd. …

Provectus starts compassionate use program for PV-10

Provectus Pharmaceuticals, Inc. (OTCBB: PVCT) expanded its compassionate use program for PV-10, making the agent, …

Positive Palifosfamide Sarcoma Phase II Data from ZIOPHARM

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced positive data from the multicenter randomized Phase II trial …

"Politics, Not Science" Holding Back Europe's Farmers

This week Truth About Trade and Technology (TATT) is hosting its fourth Global Farmer to …

Positive clinical trial results for Epeius

Epeius Biotechnologies Corporation announced results of its Rexin-G®  clinical trials. Administered as stand-alone therapy in …